Chinese consensus guidelines for diagnosis and management of gastrointestinal stromal tumor

被引：132

作者：

Li, Jian ^{[1
]}

Ye, Yingjiang ^{[2
]}

Wang, Jian ^{[3
]}

Zhang, Bo ^{[4
]}

Qin, Shukui ^{[5
]}

Shi, Yingqiang ^{[6
]}

He, Yulong ^{[7
]}

Liang, Xiaobo ^{[8
]}

Liu, Xiufeng ^{[5
]}

Zhou, Ye ^{[6
]}

Wu, Xin ^{[9
]}

Zhang, Xinhua ^{[7
]}

Wang, Ming ^{[10
]}

Gao, Zhidong ^{[2
]}

Lin, Tianlong ^{[10
]}

Cao, Hui ^{[10
]}

Shen, Lin ^{[1
]}

机构：

[1] Peking Univ, Canc Hosp & Inst, Dept Gastrointestinal Oncol, Key Lab Carcinogenesis & Translat Res,Minist Educ, Beijing 100142, Peoples R China

[2] Peking Univ, Peoples Hosp, Dept Gastrointestinal Surg, Beijing 100044, Peoples R China

[3] Fudan Univ, Zhongshan Hosp, Dept Pathol, Shanghai 200032, Peoples R China

[4] Sichuan Univ, Huaxi Hosp, Dept Gastrointestinal Surg, Chengdu 610041, Sichuan, Peoples R China

[5] 81St Hosp Peoples Liberat Army, Peoples Liberat Army Canc Ctr, Dept Med Oncol, Nanjing 210002, Jiangsu, Peoples R China

[6] Fudan Univ, Canc Hosp, Dept Gastr Surg, Shanghai 200032, Peoples R China

[7] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Gastrointestinal Surg, Guangzhou 510080, Guangdong, Peoples R China

[8] Shanxi Prov Canc Hosp, Dept Gastrointestinal Surg, Taiyuan 030013, Shanxi, Peoples R China

[9] Chinese Peoples Liberat Army Gen Hosp, Dept Gen Surg, Beijing 100853, Peoples R China

[10] Shanghai Jiao Tong Univ, Sch Med, Ren Ji Hosp, Dept Gen Surg, Shanghai 200127, Peoples R China

来源：

CHINESE JOURNAL OF CANCER RESEARCH | 2017年 / 29卷 / 04期

关键词：

Gastrointestinal stromal tumor; diagnosis; therapy; consensus; ADJUVANT IMATINIB MESYLATE; V600E BRAF MUTATIONS; WILD-TYPE GIST; SUCCINATE-DEHYDROGENASE; RESPONSE EVALUATION; CLINICAL-PRACTICE; RANDOMIZED-TRIAL; FOLLOW-UP; KIT; EFFICACY;

D O I：

10.21147/j.issn.1000-9604.2017.04.01

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

In order to further promote the standardization of diagnosis and treatment of gastrointestinal stromal tumor (GIST) in China, the members of Chinese Society of Clinical Oncology (CSCO) Expert Committee on GIST thoroughly discussed the key contents of the consensus guidelines, and voted on the controversial issue. In final, the Chinese consensus guidelines for the diagnosis and management of GIST (2017 edition) was formed on the basis of 2013 edition consensus guidelines, which is hereby announced. The consensus included the pathological diagnosis, recurrence risk classification evaluation, targeted agent therapy, surgery and principles of surveillance of GIST.

引用

页码：281 / 293

页数：13

共 63 条

[1] V600E BRAF mutations are alternative early molecular events in a subset of KIT/PDGFRA wild-type gastrointestinal stromal tumours
Agaimy, A.
Terracciano, L. M.
Dirnhofer, S.
Tornillo, L.
Foerster, A.
Hartmann, A.
Bihl, M. P.
[J]. JOURNAL OF CLINICAL PATHOLOGY, 2009, 62 (07) : 613 - 616
[2] Novel V600E BRAF mutations in imatinib-naive and imatinib-resistant gastrointestinal stromal tumors
Agaram, Narasimhan P.
Wong, Grace C.
Guo, Tianhua
Maki, Robert G.
Singer, Samuel
DeMatteo, Ronald P.
Besmer, Peter
Antonescu, Cristina R.
[J]. GENES CHROMOSOMES & CANCER, 2008, 47 (10) : 853 - 859
[3] Comparative ultrastructural analysis and KIT/PDGFRA genotype in 125 gastrointestinal stromal tumors
Agaram, Narasimhan P.
Baren, Ann
Arkun, Knarik
DeMatteo, Ronald P.
Besmer, Peter
Antonescu, Cristina R.
[J]. ULTRASTRUCTURAL PATHOLOGY, 2006, 30 (06) : 443 - 452
[4] NF1-associated gastrointestinal stromal tumors have unique clinical, phenotypic and genotypic characteristics
Andersson, J
Sihto, H
Meis-Kindblom, JM
Joensuu, H
Nupponen, N
Kindblom, LG
[J]. AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2005, 29 (09) : 1170 - 1176
[5] Neoadjuvant imatinib in patients with locally advanced non metastatic GIST in the prospective BFR14 trial
Blesius, Aurore
Cassier, Philippe A.
Bertucci, Francois
Fayette, Jerome
Ray-Coquard, Isabelle
Bui, Binh
Adenis, Antoine
Rios, Maria
Cupissol, Didier
Perol, David
Blay, Jean-Yves
Le Cesne, Axel
[J]. BMC CANCER, 2011, 11
[6] Transcriptome sequencing identifies ETV6-NTRK3 as a gene fusion involved in GIST
Brenca, Monica
Rossi, Sabrina
Polano, Maurizio
Gasparotto, Daniela
Zanatta, Lucia
Racanelli, Dominga
Valori, Laura
Lamon, Stefano
Dei Tos, Angelo Paolo
Maestro, Roberta
[J]. JOURNAL OF PATHOLOGY, 2016, 238 (04) : 543 - 549
[7] Transcatheter arterial chemoembolization for gastrointestinal stromal tumors with liver metastases
Cao, Guang
Li, Jian
Shen, Lin
Zhu, Xu
[J]. WORLD JOURNAL OF GASTROENTEROLOGY, 2012, 18 (42) : 6134 - 6140
[8] Response evaluation of gastrointestinal stromal tumors
Choi, Haesun
[J]. ONCOLOGIST, 2008, 13 : 4 - 7
[9] Spectrum of KIT/PDGFRA/BRAF mutations and Phosphatidylinositol-3-Kinase pathway gene alterations in gastrointestinal stromal tumors (GIST)
Daniels, Marc
Lurkin, Irene
Pauli, Roland
Erbstoesser, Erhard
Hildebrandt, Uwe
Hellwig, Karsten
Zschille, Uwe
Lueders, Petra
Krueger, Gabriele
Knolle, Juergen
Stengel, Bernd
Prall, Friedrich
Hertel, Kay
Lobeck, Hartmut
Popp, Brigitte
Theissig, Franz
Wuensch, Peter
Zwarthoff, Ellen
Agaimy, Abbas
Schneider-Stock, Regine
[J]. CANCER LETTERS, 2011, 312 (01) : 43 - 54
[10] Adjuvant imatinib mesylate after resection of localised, primary gastrointestinal stromal tumour: a randomised, double-blind, placebo-controlled trial
DeMatteo, Ronald P.
Ballman, Karla V.
Antonescu, Cristina R.
Maki, Robert G.
Pisters, Peter W. T.
Demetri, George D.
Blackstein, Martin E.
Blanke, Charles D.
von Mehren, Margaret
Brennan, Murray F.
Patel, Shreyaskumar
McCarter, Martin D.
Polikoff, Jonathan A.
Tan, Benjamin R.
Owzar, Kouros
[J]. LANCET, 2009, 373 (9669) : 1097 - 1104

← 1 2 3 4 5 6 7 →